Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass grafting

Pramod Kuchulakanti, Emmanouil I. Kapetanakis, Robert Lew, Seung Woon Rha, Edouard Cheneau, Lowell F. Satler, William O. Suddath, Augusto D. Pichard, Kenneth M. Kent, Rajbabu Pakala, Elizabeth Haile, Paul Corso, Ron Waksman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Pre-treatment of patients with clopidogrel prior to coronary angiography (CAG) and possible percutaneous coronary intervention (PCI) is a standard practice. Candidates for coronary artery bypass surgery (CABG) are discharged or remain in the hospital until CABG after clopidogrel is discontinued. We investigated whether any differences exist in the rates of surgical complications and outcomes between these two groups of patients. We conclude that continued hospitalization of clopidogrel pre-treated patients does not confer any safety benefit with regard to post-operative complications and 30-day mortality. Discharging these patients after CAG may reduce hospitalization costs.

Original languageEnglish
Pages (from-to)5-7
Number of pages3
JournalJournal of Invasive Cardiology
Volume17
Issue number1
Publication statusPublished - 2005 Jan 1

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kuchulakanti, P., Kapetanakis, E. I., Lew, R., Rha, S. W., Cheneau, E., Satler, L. F., Suddath, W. O., Pichard, A. D., Kent, K. M., Pakala, R., Haile, E., Corso, P., & Waksman, R. (2005). Impact of continued hospitalization in patients pre-treated with clopidogrel prior to coronary angiography and undergoing coronary artery bypass grafting. Journal of Invasive Cardiology, 17(1), 5-7.